TRANSMISSION OF ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS FOLLOWING DELIBERATE INJECTION OF BLOOD FROM A PATIENT WITH AIDS - CHARACTERISTICS AND NATURAL-HISTORY OF THE VIRUS

被引:56
作者
VEENSTRA, J
SCHUURMAN, R
CORNELISSEN, M
VANTWOUT, AB
BOUCHER, CAB
SCHUITEMAKER, H
GOUDSMIT, J
COUTINHO, RA
机构
[1] ACAD MED CTR,DEPT VIROL,AMSTERDAM,NETHERLANDS
[2] UNIV AMSTERDAM,NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,DEPT CLIN VIROIMMUNOL,AMSTERDAM,NETHERLANDS
[3] UNIV AMSTERDAM,EXPTL & CLIN IMMUNOL LAB,AMSTERDAM,NETHERLANDS
[4] UNIV AMSTERDAM,ACAD MED CTR,DEPT INTERNAL MED,DIV INFECT DIS TROP MED & AIDS,1105 AZ AMSTERDAM,NETHERLANDS
关键词
D O I
10.1093/clinids/21.3.556
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We describe the development and persistence of severe immunodeficiency in a previously healthy young woman shortly after she was deliberately injected with blood that was drawn from a patient with AIDS. The heterogenous populations of human immunodeficiency virus (HIV) in donor and recipient were as closely related as those reported in previous cases of proven transmission. The relatively large proportion of non-syncytium-inducing (NSI) clones in the recipient suggests a selective but not complete suppression of syncytium-inducing (ST) viruses. The continuous presence of SI viruses might explain the severe immunosuppression that persisted once the recipient seroconverted. A codon 215 mutation (indicative of zidovudine resistance) was present in SI and NSI clones of the donor and in NSI clones of the recipient. The relative increase in codon 215 resistance mutation in the absence of zidovudine therapy was secondary to the increase in NSI clones. Findings in this case suggest that qualities of an inoculum and/or the route of transmission are important determinants in the subsequent clinical course of HIV disease.
引用
收藏
页码:556 / 560
页数:5
相关论文
共 24 条
  • [1] HIV-INFECTION IN RECIPIENTS OF BLOOD PRODUCTS FROM DONORS WITH KNOWN DURATION OF INFECTION
    ASHTON, LJ
    LEARMONT, J
    LUO, K
    WYLIE, B
    STEWART, G
    KALDOR, JM
    [J]. LANCET, 1994, 344 (8924) : 718 - 720
  • [2] BOOM R, 1991, J CLIN MICROBIOL, V28, P495
  • [3] SYNCYTIUM-INDUCING (SI) PHENOTYPE SUPPRESSION AT SEROCONVERSION AFTER INTRAMUSCULAR INOCULATION OF A NON-SYNCYTIUM-INDUCING/SI PHENOTYPICALLY MIXED HUMAN-IMMUNODEFICIENCY-VIRUS POPULATION
    CORNELISSEN, M
    MULDERKAMPINGA, G
    VEENSTRA, J
    ZORGDRAGER, F
    KUIKEN, C
    HARTMAN, S
    DEKKER, J
    VANDERHOEK, L
    SOL, C
    COUTINHO, R
    GOUDSMIT, J
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (03) : 1810 - 1818
  • [4] DENTAL HIV TRANSMISSION
    DEBRY, RW
    ABELE, LG
    WEISS, SH
    HILL, MD
    BOUZAS, M
    LORENZO, E
    GRAEBNITZ, F
    RESNICK, L
    [J]. NATURE, 1993, 361 (6414) : 691 - 691
  • [5] HAMMING RW, 1986, CODING INFORMATION T
  • [6] HIV TRANSMISSION BY STABBING DESPITE ZIDOVUDINE PROPHYLAXIS
    JONES, PD
    [J]. LANCET, 1991, 338 (8771) : 884 - 884
  • [7] A MICROTITRE FORMAT POINT MUTATION ASSAY - APPLICATION TO THE DETECTION OF DRUG-RESISTANCE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTED PATIENTS TREATED WITH ZIDOVUDINE
    KAYE, S
    LOVEDAY, C
    TEDDER, RS
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1992, 37 (04) : 241 - 246
  • [9] PROGNOSTIC VALUE OF HIV-1 SYNCYTIUM-INDUCING PHENOTYPE FOR RATE OF CD4+ CELL DEPLETION AND PROGRESSION TO AIDS
    KOOT, M
    KEET, IPM
    VOS, AHV
    DEGOEDE, REY
    ROOS, MTL
    COUTINHO, RA
    MIEDEMA, F
    SCHELLEKENS, PTA
    TERSMETTE, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) : 681 - 688
  • [10] HIV-1 BIOLOGICAL PHENOTYPE IN LONG-TERM INFECTED INDIVIDUALS EVALUATED WITH AN MT-2 COCULTIVATION ASSAY
    KOOT, M
    VOS, AHV
    KEET, RPM
    DEGOEDE, REY
    DERCKSEN, MW
    TERPSTRA, FG
    COUTINHO, RA
    MIEDEMA, F
    TERSMETTE, M
    [J]. AIDS, 1992, 6 (01) : 49 - 54